허혈성 뇌졸중 환자에서의 Thrombin Activable Fibrinolysis Inhibitor의 의의

참고문헌 (17)

1. "Purification and characterizationof TAFI,a thrombin-activatable fibrinolysis inhibibitor", 270, pp.14477~14484 (1995)
2. "Thrombin activatable fibrinolysis inhibitor and an antifib-rinolytic pathway", 20, pp.2511~2518 (2000)
3. "Regulation of fibrinolysis inplasma by TAFI and protein C is dependent on the concentrationof thrombomodulin", 85, pp.5~11 (2001)
4. "Factor XI dependentand independent activation of thrombin activatable fibrinolysis in-hibitor(TAFI)in plasma associated with clot formation", 82, pp.1703~1708 (1999)
5. "A study ofthe mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor", 273, pp.27176~27181 (1998)
6. "PlasmaTAFI levels influence the clot lysis time in healthy individuals in thepresence of an intact intrinsic pathway of coagulation", 80, pp.829~835 (1998)
7. "Plasma procarboxypeptidase U in men with symptomaticcoronary artery disease", 84, pp.364~368 (2000)
8. "Thrombin activatablefibrinolysis inhibitor and the risk for deep vein thrombosis", 95, pp.2855~2859 (2000)
9. "Identification of polymorphism in the promoter and the 3 region ofthe TAFI gene:evidence that plasma TAFI antigen levels are stronglygenetically controlled", 97, pp.2053~2058 (2001)
10. "Plas-ma TAFI antigen variations in healthy subjects", 83, pp.902~905 (2000)
11. "Thrombin-activable fibrinolysis inhibitor antigenlevels and cardiovascular risk factors", 20, pp.2156~2161 (2000)
12. "Characteri-zation of the gene encoding human TAFI (Thrmobin-activable fib-rinolysis inhibitor; plasma procarboxypeptidase B).", 38, pp.6547~6558 (1999)
13. "Plasma thrombin-activatable fibrinolysis inhibitor antigenconcentration and genotype in relation to myocardial infarction inthe north and south of Europe", 22, pp.867~873 (2002)
14. "Risk of ischemic stroke associated with functional thrombin-aci-batiable fibrinolysis inhibitor plasma levels", 34, pp.2387~2391 (2003)
15. "Thrombin-activable fibrinolysis inhibitor levels in the acute phase of ischemicstroke", 34, pp.1038~1040 (2003)
16. "Admission fibrinolytic profile is associated with symptomatichemorrhagic transformation in stroke patients treated withtissue plasminogen activator", 35, pp.2123~2127 (2004)
17. "활성화C 단백내성검사의정도관리와한국인의양성률", 16, pp.815~826 (1996)

관련 논문AI추천